Reference
van der Have M, et al. Optimizing Screening for Tuberculosis and Hepatitis B Prior to Starting Tumor Necrosis Factor-alpha Inhibitors in Crohn's Disease. Digestive Diseases and Sciences : 15 Aug 2013. Available from: URL: http://dx.doi.org/10.1007/s10620-013-2820-9
Rights and permissions
About this article
Cite this article
Extensive TB and HBV screening prior to infliximab not worthwhile. PharmacoEcon Outcomes News 686, 5 (2013). https://doi.org/10.1007/s40274-013-0678-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0678-x